Piperochromanoic acid



Compound IDCDAMM00957
Common namePiperochromanoic acid
IUPAC name2-(4,8-dimethylnona-3,7-dienyl)-8-hydroxy-3-methylidene-4H-chromene-6-carboxylic acid
Molecular formulaC22H28O4

Experimental data

Retention time10.7
Adduct[M+H]+
Actual mz357.209
Theoretical mz357.206
Error7.07
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.578

Identifiers and class information

Inchi keyXBOKPWYVDNVFMX-DHDCSXOGNA-N
SmilesO=C(O)C1=CC(O)=C2OC(C(=C)CC2=C1)CCC=C(C)CCC=C(C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)8
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)356.461
Computed dipole moment(dipole)6.941
Total solvent accessible surface area (SASA)714.639
Hydrophobic component of SASA (FOSA)440.297
Hydrophilic component of SASA (FISA)152.403
Pie component of the SASA (PISA)121.939
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1269.23
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)3.5
Free energy of solvation of dipole (dip^2/V)0.0379615
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0069262
Globularity descriptor (glob)0.793303
Predicted polarizability in cubic angstroms (QPpolrz)40.668
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.456
Predicted octanol/gas partition coefficient (QPlogPoct)18.422
Predicted water/gas partition coefficient (QPlogPw)7.917
Predicted octanol/water partition coefficient (QPlogPo/w)5.182
Predicted aqueous solubility (QPlogS)-6.514
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.418
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.651
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)90.004
Predicted brain/blood partition coefficient (QPlogBB)-1.533
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)46.609
Predicted skin permeability, log Kp (QPlogKp)-3.131
PM3 calculated ionization potential (IP(ev))9.27
PM3 calculated electron affinity (EA(eV))0.512
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)0.796
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)79.308
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)79.252
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P06241FYNTyrosine-protein kinase FYNT17980SwissTargetPrediction
P29274ADORA2AAdenosine A2a receptorT77365SwissTargetPrediction
P12821ACEAngiotensin-converting enzymeT98311SwissTargetPrediction
P42336PIK3CAPI3-kinase p110-alpha subunitT80276SwissTargetPrediction
P21554CNR1Cannabinoid receptor 1 (by homology)T76685SwissTargetPrediction
P14867GABRA1GABA-A receptor; alpha-1/beta-2/gamma-2T51487SwissTargetPrediction
P29275ADORA2BAdenosine A2b receptorT86679SwissTargetPrediction
O60885BRD4Bromodomain-containing protein 4T00407SwissTargetPrediction
O00519FAAHAnandamide amidohydrolaseT11754SwissTargetPrediction
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SwissTargetPrediction
P15090FABP4Fatty acid binding protein adipocyteT07217SwissTargetPrediction
Q01469FABP5Fatty acid binding protein epidermalT21507SwissTargetPrediction
P30307CDC25CDual specificity phosphatase Cdc25CT40569SwissTargetPrediction
Q13547HDAC1Histone deacetylase 1T68547SwissTargetPrediction
P21731TBXA2RThromboxane A2 receptorT76198SwissTargetPrediction
P00519ABL1Tyrosine-protein kinase ABLT63505SwissTargetPrediction
P24941CDK2Cyclin-dependent kinase 2T70176SwissTargetPrediction
P36888FLT3Tyrosine-protein kinase receptor FLT3T74312SwissTargetPrediction
O14965AURKASerine/threonine-protein kinase Aurora-AT87675SwissTargetPrediction
Q06124PTPN11Protein-tyrosine phosphatase 2CT13057SwissTargetPrediction
P20701ITGALIntercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2T35640SwissTargetPrediction
P49841GSK3BGlycogen synthase kinase-3 betaT70977SwissTargetPrediction
P07900HSP90AA1Heat shock protein HSP 90-alphaT18477SwissTargetPrediction
P30556AGTR1Type-1 angiotensin II receptorT74456SwissTargetPrediction
O00329PIK3CDPI3-kinase p110-delta subunitT67849SwissTargetPrediction
P17948FLT1Vascular endothelial growth factor receptor 1T63966SwissTargetPrediction
P35916FLT4Vascular endothelial growth factor receptor 3T07303SwissTargetPrediction
O00444PLK4Serine/threonine-protein kinase PLK4T71374SwissTargetPrediction
P34972CNR2Cannabinoid receptor 2T37693SwissTargetPrediction
P43115PTGER3Prostanoid EP3 receptorT85467SwissTargetPrediction
Q14289PTK2BProtein tyrosine kinase 2 betaT07087SwissTargetPrediction
Q9Y2K7KDM2ALysine-specific demethylase 2AT71949SwissTargetPrediction
P49840GSK3AGlycogen synthase kinase-3 alphaT76910SwissTargetPrediction
P49760CLK2Dual specificity protein kinase CLK2T73725SwissTargetPrediction
P49761CLK3Dual specificity protein kinase CLK3T21585SwissTargetPrediction
P16591FERTyrosine-protein kinase FERT16993SwissTargetPrediction
P08922ROS1Proto-oncogene tyrosine-protein kinase ROST69128SwissTargetPrediction
Q13258PTGDRProstanoid DP receptorT68782SwissTargetPrediction
P32239CCKBRCholecystokinin B receptor (by homology)T05849SwissTargetPrediction
P48736PIK3CGPI3-kinase p110-gamma subunitT95913SwissTargetPrediction
P68400CSNK2A1Casein kinase II alphaT51565SwissTargetPrediction
Q6ZMT4KDM7ALysine-specific demethylase 7A/7BT18784SwissTargetPrediction
P04049RAF1Serine/threonine-protein kinase RAFT51883SwissTargetPrediction
Q06187BTKTyrosine-protein kinase BTKT97719SwissTargetPrediction
P16234PDGFRAPlatelet-derived growth factor receptorT53524SwissTargetPrediction
P29317EPHA2Ephrin type-A receptor 2T57278SwissTargetPrediction
Q02763TEKTyrosine-protein kinase TIE-2T92144SwissTargetPrediction
Q9Y5X9LIPGEndothelial lipaseT19368SwissTargetPrediction
P08631HCKTyrosine-protein kinase HCKT31406SwissTargetPrediction
P51451BLKTyrosine-protein kinase BLKT74307SwissTargetPrediction
Q15418RPS6KA1Ribosomal protein S6 kinase alpha 1T83202SwissTargetPrediction
P41240CSKTyrosine-protein kinase CSKT08741SwissTargetPrediction
P22607FGFR3Fibroblast growth factor receptor 3T91331SwissTargetPrediction
P51813BMXTyrosine-protein kinase BMXT99990SwissTargetPrediction
P07948LYNTyrosine-protein kinase LynT68163SwissTargetPrediction
P27448MARK3Serine/threonine-protein kinase c-TAK1T90553SwissTargetPrediction
P09769FGRTyrosine-protein kinase FGRT49925SwissTargetPrediction
P29320EPHA3Ephrin type-A receptor 3T28413SwissTargetPrediction
Q08345DDR1Epithelial discoidin domain-containing receptor 1T09185SwissTargetPrediction
Q92523CPT1BCarnitine O-palmitoyltransferase 1, muscle isoform (by homology)T75888SwissTargetPrediction
Q16548BCL2A1Bcl-2-related protein A1 (by homology)T12797SwissTargetPrediction
Q12866MERTKProto-oncogene tyrosine-protein kinase MERT55781SwissTargetPrediction
Q06418TYRO3Tyrosine-protein kinase receptor TYRO3T94880SwissTargetPrediction
P63316TNNC1Troponin, cardiac muscleT12966SwissTargetPrediction
P30530AXLTyrosine-protein kinase receptor UFOT82383SwissTargetPrediction
Q92843BCL2L2Apoptosis regulator Bcl-WT03755SwissTargetPrediction
Q9UPP1PHF8Histone lysine demethylase PHF8T00933SwissTargetPrediction
P28702RXRBRetinoid X receptor betaT60077SwissTargetPrediction
Q9UQB9AURKCSerine/threonine-protein kinase Aurora-CT97592SwissTargetPrediction
P54756EPHA5Ephrin type-A receptor 5T18474SwissTargetPrediction
P54764EPHA4Ephrin type-A receptor 4T70234SwissTargetPrediction
Q9UF33EPHA6Ephrin type-A receptor 6T08647SwissTargetPrediction
P54753EPHB3Ephrin type-B receptor 3T56121SwissTargetPrediction
P21802FGFR2Fibroblast growth factor receptor 2T58454SwissTargetPrediction
P42229STAT5ASignal transducer and activator of transcription 5AT20027SwissTargetPrediction
Q9Y256RCE1Prenyl protein specific proteaseT10756SwissTargetPrediction
Q13470TNK1Non-receptor tyrosine-protein kinase TNK1T91598SwissTargetPrediction
P21709EPHA1Ephrin type-A receptor 1T28418SwissTargetPrediction
Q15375EPHA7Ephrin type-A receptor 7T57006SwissTargetPrediction
P54762EPHB1Ephrin type-B receptor 1T02446SwissTargetPrediction
P57059SIK1Serine/threonine-protein kinase SIK1T11317SwissTargetPrediction
Q9UEE5STK17ASerine/threonine-protein kinase 17AT91323SwissTargetPrediction
P42684ABL2Tyrosine-protein kinase ABL2T83009SwissTargetPrediction
P42680TECTyrosine-protein kinase TECT15848SwissTargetPrediction
Q9Y616IRAK3Interleukin-1 receptor-associated kinase 3T87981SwissTargetPrediction
P35590TIE1Tyrosine-protein kinase receptor Tie-1T98539SwissTargetPrediction
O95749GGPS1GeranyltranstransferaseT86528SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T17980DI0286Myeloproliferative neoplasm[ICD-11: 2A20]P06241FYN
T77365DI0319Orthostatic hypotension[ICD-11: BA21]P29274ADORA2A
T77365DI0331Parkinsonism[ICD-11: 8A00]P29274ADORA2A
T77365DI0359Radionuclide imaging[ICD-11: N.A.]P29274ADORA2A
T98311DI0175Heart failure[ICD-11: BD10-BD1Z]P12821ACE
T98311DI0190Hypertension[ICD-11: BA00-BA04]P12821ACE
T80276DI0062Breast cancer[ICD-11: 2C60-2C6Y]P42336PIK3CA
T80276DI0151Follicular lymphoma[ICD-11: 2A80]P42336PIK3CA
T80276DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P42336PIK3CA
T76685DI0031Anorexia nervosa[ICD-11: 6B80]P21554CNR1
T76685DI0214Insomnia[ICD-11: 7A00-7A0Z]P21554CNR1
T76685DI0308Obesity[ICD-11: 5B80-5B81]P21554CNR1
T51487DI0014Acute respiratory distress syndrome[ICD-11: CB00]P14867GABRA1
T51487DI0033Anxiety disorder[ICD-11: 6B00-6B0Z]P14867GABRA1
T51487DI0082Chronic insomnia[ICD-11: 7A00]P14867GABRA1
T51487DI0087Chronic pain[ICD-11: MG30]P14867GABRA1
T51487DI0101Corneal disease[ICD-11: 9A76-9A78]P14867GABRA1
T51487DI0112Cystitis[ICD-11: GC00]P14867GABRA1
T51487DI0117Depression[ICD-11: 6A70-6A7Z]P14867GABRA1
T51487DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P14867GABRA1
T51487DI0173Headache[ICD-11: 8A80-8A84]P14867GABRA1
T51487DI0214Insomnia[ICD-11: 7A00-7A0Z]P14867GABRA1
T51487DI0243Malaria[ICD-11: 1F40-1F45]P14867GABRA1
T51487DI0256Mental/behavioural/neurodevelopmental disorder[ICD-11: 6E20-6E8Z]P14867GABRA1
T51487DI0411Tonus and reflex abnormality[ICD-11: MB47]P14867GABRA1
T86679DI0180Herpes simplex infection[ICD-11: 1F00]P29275ADORA2B
T86679DI0397Supraventricular tachyarrhythmia[ICD-11: BC81]P29275ADORA2B
T11754DI0101Corneal disease[ICD-11: 9A76-9A78]O00519FAAH
T68547DI0274Multiple myeloma[ICD-11: 2A83]Q13547HDAC1
T68547DI0283Mycosis fungoides[ICD-11: 2B01]Q13547HDAC1
T76198DI0102Coronary atherosclerosis[ICD-11: BA52]P21731TBXA2R
T76198DI0121Diabetic foot ulcer[ICD-11: BD54]P21731TBXA2R
T76198DI0287Myocardial infarction[ICD-11: BA41-BA43]P21731TBXA2R
T76198DI0378Sexual dysfunction[ICD-11: HA00-HA01]P21731TBXA2R
T63505DI0062Breast cancer[ICD-11: 2C60-2C6Y]P00519ABL1
T63505DI0220Ischemia[ICD-11: 8B10-8B11]P00519ABL1
T63505DI0250Mature B-cell lymphoma[ICD-11: 2A85]P00519ABL1
T63505DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P00519ABL1
T70176DI0060Brain cancer[ICD-11: 2A00]P24941CDK2
T70176DI0062Breast cancer[ICD-11: 2C60-2C6Y]P24941CDK2
T70176DI0238Lung cancer[ICD-11: 2C25]P24941CDK2
T70176DI0241Lymphoma[ICD-11: 2A80-2A86]P24941CDK2
T70176DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P24941CDK2
T70176DI0303Non-small-cell lung cancer[ICD-11: 2C25]P24941CDK2
T70176DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P24941CDK2
T70176DI0406Thymoma[ICD-11: 2C27]P24941CDK2
T74312DI0012Acute myeloid leukaemia[ICD-11: 2A60]P36888FLT3
T74312DI0058Bone/articular cartilage neoplasm[ICD-11: 2F7B]P36888FLT3
T74312DI0095Colorectal cancer[ICD-11: 2B91]P36888FLT3
T74312DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]P36888FLT3
T74312DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P36888FLT3
T74312DI0248Mastocytosis[ICD-11: 2A21]P36888FLT3
T74312DI0250Mature B-cell lymphoma[ICD-11: 2A85]P36888FLT3
T74312DI0286Myeloproliferative neoplasm[ICD-11: 2A20]P36888FLT3
T87675DI0009Acute diabete complication[ICD-11: 5A2Y]O14965AURKA
T87675DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]O14965AURKA
T13057DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q06124PTPN11
T35640DI0351Psoriasis[ICD-11: EA90]P20701ITGAL
T35640DI0436Visual system disease[ICD-11: 9E1Z]P20701ITGAL
T70977DI0288Myotonic disorder[ICD-11: 8C71]P49841GSK3B
T18477DI0015Acute upper respiratory infection[ICD-11: CA07]P07900HSP90AA1
T18477DI0037Asthma[ICD-11: CA23]P07900HSP90AA1
T74456DI0137Essential hypertension[ICD-11: BA00]P30556AGTR1
T74456DI0190Hypertension[ICD-11: BA00-BA04]P30556AGTR1
T74456DI0373Secondary hypertension[ICD-11: BA04]P30556AGTR1
T74456DI0425Urinary system clinical symptom[ICD-11: MF8Y]P30556AGTR1
T67849DI0151Follicular lymphoma[ICD-11: 2A80]O00329PIK3CD
T67849DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]O00329PIK3CD
T67849DI0249Mature B-cell leukaemia[ICD-11: 2A82]O00329PIK3CD
T67849DI0250Mature B-cell lymphoma[ICD-11: 2A85]O00329PIK3CD
T67849DI0395Stomach cancer[ICD-11: 2B72]O00329PIK3CD
T63966DI0361Renal cell carcinoma[ICD-11: 2C90]P17948FLT1
T07303DI0361Renal cell carcinoma[ICD-11: 2C90]P35916FLT4
T71374DI0062Breast cancer[ICD-11: 2C60-2C6Y]O00444PLK4
T37693DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]P34972CNR2
T37693DI0214Insomnia[ICD-11: 7A00-7A0Z]P34972CNR2
T85467DI0166Glaucoma[ICD-11: 9C61]P43115PTGER3
T85467DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P43115PTGER3
T85467DI0414Transplanted organ/tissue[ICD-11: QB63]P43115PTGER3
T76910DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P49840GSK3A
T69128DI0238Lung cancer[ICD-11: 2C25]P08922ROS1
T69128DI0303Non-small-cell lung cancer[ICD-11: 2C25]P08922ROS1
T68782DI0102Coronary atherosclerosis[ICD-11: BA52]Q13258PTGDR
T05849DI0122Diagnostic imaging[ICD-11: N.A.]P32239CCKBR
T05849DI0327Pancreatic internal secretion disorder[ICD-11: 5A4Y]P32239CCKBR
T95913DI0151Follicular lymphoma[ICD-11: 2A80]P48736PIK3CG
T95913DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P48736PIK3CG
T95913DI0249Mature B-cell leukaemia[ICD-11: 2A82]P48736PIK3CG
T51565DI0104Coronavirus infection[ICD-11: 1D92]P68400CSNK2A1
T51565DI0235Liver cancer[ICD-11: 2C12]P68400CSNK2A1
T51565DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P68400CSNK2A1
T51883DI0252Melanoma[ICD-11: 2C30]P04049RAF1
T51883DI0303Non-small-cell lung cancer[ICD-11: 2C25]P04049RAF1
T51883DI0321Ovarian cancer[ICD-11: 2C73]P04049RAF1
T51883DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P04049RAF1
T97719DI0231Leukaemia[ICD-11: 2A60-2B33]Q06187BTK
T53524DI0160Gastrointestinal stromal tumour[ICD-11: 2B5B]P16234PDGFRA
T53524DI0225Kaposi sarcoma[ICD-11: 2B57]P16234PDGFRA
T53524DI0403Thrombocytopenia[ICD-11: 3B64]P16234PDGFRA
T57278DI0060Brain cancer[ICD-11: 2A00]P29317EPHA2
T57278DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P29317EPHA2
T92144DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q02763TEK
T92144DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]Q02763TEK
T92144DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q02763TEK
T92144DI0286Myeloproliferative neoplasm[ICD-11: 2A20]Q02763TEK
T92144DI0365Retinopathy[ICD-11: 9B71]Q02763TEK
T92144DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q02763TEK
T19368DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]Q9Y5X9LIPG
T19368DI0091Coagulation defect[ICD-11: 3B10]Q9Y5X9LIPG
T19368DI0102Coronary atherosclerosis[ICD-11: BA52]Q9Y5X9LIPG
T31406DI0207Indeterminate colitis[ICD-11: DD72]P08631HCK
T83202DI0249Mature B-cell leukaemia[ICD-11: 2A82]Q15418RPS6KA1
T91331DI0102Coronary atherosclerosis[ICD-11: BA52]P22607FGFR3
T91331DI0235Liver cancer[ICD-11: 2C12]P22607FGFR3
T91331DI0287Myocardial infarction[ICD-11: BA41-BA43]P22607FGFR3
T68163DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]P07948LYN
T68163DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P07948LYN
T90553DI0334Peritoneal cancer[ICD-11: 2C51]P27448MARK3
T90553DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P27448MARK3
T28413DI0012Acute myeloid leukaemia[ICD-11: 2A60]P29320EPHA3
T28413DI0060Brain cancer[ICD-11: 2A00]P29320EPHA3
T28413DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P29320EPHA3
T28413DI0284Myelodysplastic syndrome[ICD-11: 2A37]P29320EPHA3
T75888DI0030Angina pectoris[ICD-11: BA40]Q92523CPT1B
T75888DI0265Mild neurocognitive disorder[ICD-11: 6D71]Q92523CPT1B
T75888DI0306Nutritional deficiency[ICD-11: 5B50-5B71]Q92523CPT1B
T55781DI0012Acute myeloid leukaemia[ICD-11: 2A60]Q12866MERTK
T55781DI0025Alzheimer disease[ICD-11: 8A20]Q12866MERTK
T55781DI0284Myelodysplastic syndrome[ICD-11: 2A37]Q12866MERTK
T55781DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q12866MERTK
T94880DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q06418TYRO3
T12966DI0006Acquired cutaneous blood vessel malformation[ICD-11: EF20]P63316TNNC1
T12966DI0175Heart failure[ICD-11: BD10-BD1Z]P63316TNNC1
T82383DI0012Acute myeloid leukaemia[ICD-11: 2A60]P30530AXL
T03755DI0286Myeloproliferative neoplasm[ICD-11: 2A20]Q92843BCL2L2
T60077DI0225Kaposi sarcoma[ICD-11: 2B57]P28702RXRB
T97592DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]Q9UQB9AURKC
T97592DI0346Prostate cancer[ICD-11: 2C82]Q9UQB9AURKC
T97592DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9UQB9AURKC
T70234DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P54764EPHA4
T58454DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]P21802FGFR2
T58454DI0235Liver cancer[ICD-11: 2C12]P21802FGFR2
T58454DI0318Oral mucositis[ICD-11: DA01]P21802FGFR2
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1

Copyright © 2025